Sheng-jie Yu

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

High Burden of Coinfection in Systemic Lupus Erythematosus with Bronchoalveolar Lavage Confirmed Pneumocystis jirovecii Pneumonia: A Single-Center Retrospective Study.

High Burden of Coinfection in Systemic Lupus Erythematosus with Bronchoalveolar Lavage Confirmed Pneumocystis jirovecii Pneumonia: A Single-Center Retrospective Study.

Journal: Modern rheumatology
Published: December 12, 2025

House dust mite allergy exacerbates psoriasis by promoting hyperactivation of mast cells and Th17 cells.

House dust mite allergy exacerbates psoriasis by promoting hyperactivation of mast cells and Th17 cells.

Journal: International immunopharmacology
Published: April 16, 2025

RETRACTED: Yen et al. Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J. Pers. Med. 2022, 12, 1888.

RETRACTED: Yen et al. Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J. Pers. Med. 2022, 12, 1888.

Journal: Journal of personalized medicine
Published: December 31, 2024

Brevilin A inhibits IL‑17A‑induced inflammation in psoriasis by modulating HSP 70.

Brevilin A inhibits IL‑17A‑induced inflammation in psoriasis by modulating HSP 70.

Journal: Molecular medicine reports
Published: September 05, 2024

Stattic suppresses p‑STAT3 and induces cell death in T‑cell acute lymphoblastic leukemia.

Stattic suppresses p‑STAT3 and induces cell death in T‑cell acute lymphoblastic leukemia.

Journal: Molecular medicine reports
Published: August 07, 2024

IFN-γ, IL-17A, IL-4, and IL-13: Potential Biomarkers for Prediction of the Effectiveness of Biologics in Psoriasis Patients.

IFN-γ, IL-17A, IL-4, and IL-13: Potential Biomarkers for Prediction of the Effectiveness of Biologics in Psoriasis Patients.

Journal: Biomedicines
Published: April 28, 2024

Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes.

Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes.

Journal: Immunopharmacology and immunotoxicology
Published: December 07, 2023

Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression.

Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression.

Journal: Biomedical reports
Published: October 17, 2023

Regulating TKT activity inhibits proliferation of human acute lymphoblastic leukemia cells.

Regulating TKT activity inhibits proliferation of human acute lymphoblastic leukemia cells.

Journal: American journal of cancer research
Published: October 11, 2023

Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment.

Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment.

Journal: International journal of molecular sciences
Published: June 06, 2023

Immunomodulatory effects of modified Liu-Wei-Di-Huang-Wan Traditional Chinese medicine on allergic asthmatic mice.

Immunomodulatory effects of modified Liu-Wei-Di-Huang-Wan Traditional Chinese medicine on allergic asthmatic mice.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: October 06, 2022

RETRACTED: Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients.

RETRACTED: Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients.

Journal: Journal of personalized medicine
Published: September 22, 2022
Showing 1-12 of 33

Last Updated: 09/26/2026